Yuancheng Wang

14PUBLICATIONS
29CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Technical writingNaval architecture
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Systematic Review: Imaging-Based Morphological Criteria for Liver Cirrhosis-A Call to Standardise.

Mei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan

|Mar 07, 2026
MR Radiomics Combined With Radiologic Features to Predict Recurrence Location in Nonviable Hepatocellular Carcinoma After Transarterial Chemoembolization.

Shuhang Zhang, Weilang Wang, Wu Cai

|Feb 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.

Hai-Dong Zhu, Wei-Jun Fan, Chang Zhao

|Feb 05, 2026
Response to Letter to the Editor Regarding 'Practical Considerations for MRI-Derived Retreatment Response Scores in Viable HCC'.

Weilang Wang, Yuan-Cheng Wang

|Feb 03, 2026
Response to Letter to the Editor Regarding 'Considerations on MRI-Based Stratification for Retreatment After TACE in HCC'.

Weilang Wang, Yuan-Cheng Wang

|Dec 12, 2025
MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization.

Weilang Wang, Xiuming Zhang, Yixing Yu

Pageof 3

Frequent Collaborators

2 joint publications

Tianyi Xia

2 joint publications

Junhao Zha

2 joint publications

Shenghong Ju

1 joint publications

Zheng-Hao Zhou